Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitral Valve Insufficiency | 121 | 2024 | 1419 | 13.650 |
Why?
|
Mitral Valve | 97 | 2024 | 1486 | 7.960 |
Why?
|
Mitral Valve Prolapse | 40 | 2023 | 215 | 7.490 |
Why?
|
Echocardiography, Three-Dimensional | 42 | 2021 | 613 | 3.910 |
Why?
|
Papillary Muscles | 30 | 2023 | 192 | 3.230 |
Why?
|
Ventricular Remodeling | 33 | 2022 | 1261 | 2.500 |
Why?
|
Mitral Valve Stenosis | 13 | 2023 | 348 | 2.160 |
Why?
|
Myocardial Ischemia | 24 | 2021 | 2164 | 1.980 |
Why?
|
Sheep | 35 | 2022 | 1441 | 1.930 |
Why?
|
Echocardiography, Doppler | 26 | 2020 | 901 | 1.690 |
Why?
|
Chordae Tendineae | 8 | 2023 | 39 | 1.620 |
Why?
|
Heart Valve Diseases | 17 | 2024 | 1047 | 1.600 |
Why?
|
Echocardiography | 35 | 2024 | 4981 | 1.520 |
Why?
|
Myocardial Infarction | 33 | 2022 | 11891 | 1.380 |
Why?
|
Mitral Valve Annuloplasty | 8 | 2022 | 146 | 1.240 |
Why?
|
Echocardiography, Doppler, Color | 16 | 2019 | 354 | 1.230 |
Why?
|
Ventricular Dysfunction, Left | 23 | 2020 | 2128 | 1.160 |
Why?
|
Rheumatic Heart Disease | 5 | 2024 | 167 | 1.160 |
Why?
|
Ventricular Function, Left | 29 | 2023 | 3880 | 0.880 |
Why?
|
Aortic Valve Stenosis | 11 | 2023 | 2065 | 0.820 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2019 | 1311 | 0.820 |
Why?
|
Tinnitus | 5 | 2012 | 194 | 0.780 |
Why?
|
Ventricular Function | 2 | 2017 | 408 | 0.740 |
Why?
|
Tricuspid Valve Insufficiency | 5 | 2023 | 355 | 0.740 |
Why?
|
Heart Atria | 10 | 2023 | 1346 | 0.700 |
Why?
|
Aortic Valve | 10 | 2023 | 1996 | 0.680 |
Why?
|
Heart Ventricles | 15 | 2023 | 3811 | 0.670 |
Why?
|
Imaging, Three-Dimensional | 9 | 2017 | 4048 | 0.670 |
Why?
|
Hemodynamics | 16 | 2022 | 4174 | 0.640 |
Why?
|
Systole | 8 | 2020 | 947 | 0.630 |
Why?
|
Fibrosis | 11 | 2023 | 2042 | 0.620 |
Why?
|
Echocardiography, Transesophageal | 8 | 2021 | 1108 | 0.600 |
Why?
|
Adaptation, Physiological | 7 | 2018 | 1296 | 0.600 |
Why?
|
Heart Valve Prosthesis | 8 | 2024 | 1495 | 0.580 |
Why?
|
Cardiac Resynchronization Therapy | 3 | 2019 | 553 | 0.580 |
Why?
|
Atrial Function | 1 | 2017 | 99 | 0.570 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2023 | 1582 | 0.570 |
Why?
|
Myocardial Contraction | 11 | 2016 | 1516 | 0.550 |
Why?
|
Hypertension, Pulmonary | 3 | 2022 | 1570 | 0.530 |
Why?
|
Polyvinyl Alcohol | 3 | 2015 | 73 | 0.520 |
Why?
|
Stroke Volume | 24 | 2023 | 5523 | 0.510 |
Why?
|
Calcinosis | 5 | 2024 | 1476 | 0.490 |
Why?
|
Exercise Test | 9 | 2020 | 2128 | 0.480 |
Why?
|
Atrial Fibrillation | 7 | 2023 | 5209 | 0.450 |
Why?
|
Dust | 1 | 2016 | 483 | 0.440 |
Why?
|
Aortic Valve Insufficiency | 6 | 2020 | 584 | 0.440 |
Why?
|
Prolapse | 3 | 2023 | 63 | 0.430 |
Why?
|
Atrial Function, Left | 4 | 2023 | 186 | 0.430 |
Why?
|
Echocardiography, Doppler, Pulsed | 3 | 2019 | 69 | 0.430 |
Why?
|
Ventricular Function, Right | 5 | 2018 | 610 | 0.430 |
Why?
|
Humans | 172 | 2024 | 760621 | 0.420 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2019 | 571 | 0.410 |
Why?
|
Cardiac Imaging Techniques | 1 | 2015 | 269 | 0.410 |
Why?
|
Predictive Value of Tests | 24 | 2023 | 15289 | 0.390 |
Why?
|
Coronary Circulation | 4 | 2016 | 1577 | 0.370 |
Why?
|
Endothelial Cells | 7 | 2022 | 3539 | 0.370 |
Why?
|
Male | 121 | 2023 | 359744 | 0.370 |
Why?
|
Disease Models, Animal | 17 | 2018 | 18137 | 0.360 |
Why?
|
Vascular Resistance | 1 | 2013 | 933 | 0.360 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2023 | 615 | 0.350 |
Why?
|
Hypertrophy, Left Ventricular | 6 | 2017 | 854 | 0.350 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2023 | 1046 | 0.350 |
Why?
|
Heart Failure | 16 | 2023 | 11847 | 0.340 |
Why?
|
Models, Cardiovascular | 6 | 2019 | 978 | 0.340 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 128 | 0.340 |
Why?
|
Atrial Appendage | 2 | 2023 | 292 | 0.330 |
Why?
|
Severity of Illness Index | 24 | 2023 | 15840 | 0.330 |
Why?
|
Animals | 64 | 2023 | 167963 | 0.330 |
Why?
|
Middle Aged | 83 | 2023 | 220352 | 0.320 |
Why?
|
Female | 112 | 2023 | 391270 | 0.320 |
Why?
|
Aged | 71 | 2022 | 169152 | 0.290 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2019 | 1067 | 0.290 |
Why?
|
Hypertrophy | 2 | 2013 | 555 | 0.290 |
Why?
|
Exercise Tolerance | 4 | 2019 | 830 | 0.270 |
Why?
|
Vestibulocochlear Nerve Diseases | 1 | 2006 | 33 | 0.260 |
Why?
|
Genes, Dominant | 2 | 2005 | 863 | 0.250 |
Why?
|
Disease Progression | 11 | 2023 | 13502 | 0.250 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2015 | 3340 | 0.250 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2005 | 193 | 0.250 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2022 | 730 | 0.240 |
Why?
|
Heart Valves | 4 | 2019 | 285 | 0.240 |
Why?
|
Blood Pressure Monitors | 1 | 2004 | 33 | 0.240 |
Why?
|
Endocarditis | 1 | 2009 | 351 | 0.240 |
Why?
|
Extracellular Matrix | 5 | 2020 | 1726 | 0.240 |
Why?
|
Nerve Compression Syndromes | 1 | 2006 | 160 | 0.240 |
Why?
|
Cochlear Nerve | 1 | 2006 | 202 | 0.230 |
Why?
|
Losartan | 2 | 2017 | 265 | 0.230 |
Why?
|
Artifacts | 2 | 2020 | 1898 | 0.230 |
Why?
|
Aged, 80 and over | 25 | 2022 | 58995 | 0.220 |
Why?
|
Molecular Biology | 1 | 2007 | 580 | 0.220 |
Why?
|
Oxygen Consumption | 2 | 2020 | 1843 | 0.220 |
Why?
|
Myocardium | 7 | 2022 | 4700 | 0.210 |
Why?
|
Case-Control Studies | 15 | 2019 | 22053 | 0.210 |
Why?
|
Sheep, Domestic | 3 | 2017 | 50 | 0.210 |
Why?
|
Polymers | 3 | 2017 | 1621 | 0.210 |
Why?
|
Cardiac Output | 4 | 2020 | 838 | 0.200 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 252 | 0.200 |
Why?
|
Rheumatic Fever | 1 | 2022 | 75 | 0.200 |
Why?
|
Thymosin | 1 | 2022 | 47 | 0.200 |
Why?
|
Cell Transdifferentiation | 2 | 2015 | 185 | 0.200 |
Why?
|
Pulmonary Edema | 1 | 2004 | 409 | 0.190 |
Why?
|
Transforming Growth Factor beta | 4 | 2017 | 1959 | 0.190 |
Why?
|
Coronary Occlusion | 2 | 2015 | 309 | 0.190 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2010 | 8950 | 0.190 |
Why?
|
Image Enhancement | 3 | 2007 | 2881 | 0.180 |
Why?
|
Smad3 Protein | 2 | 2018 | 167 | 0.180 |
Why?
|
Heart Septum | 3 | 2010 | 303 | 0.180 |
Why?
|
Collagen Type I | 2 | 2022 | 616 | 0.180 |
Why?
|
Adult | 41 | 2023 | 219994 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 10 | 2020 | 36290 | 0.170 |
Why?
|
Treatment Outcome | 18 | 2023 | 65017 | 0.170 |
Why?
|
Exhalation | 1 | 2020 | 181 | 0.170 |
Why?
|
Lymphatic Vessels | 1 | 2024 | 358 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2018 | 474 | 0.170 |
Why?
|
Aorta, Thoracic | 2 | 2017 | 1097 | 0.170 |
Why?
|
Echocardiography, Stress | 3 | 2016 | 134 | 0.170 |
Why?
|
Contractile Proteins | 2 | 2012 | 240 | 0.160 |
Why?
|
Ultrasonography | 10 | 2015 | 5961 | 0.160 |
Why?
|
Angioplasty, Balloon | 1 | 2002 | 597 | 0.160 |
Why?
|
Prognosis | 14 | 2023 | 29658 | 0.160 |
Why?
|
Time Factors | 16 | 2019 | 40165 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2255 | 0.150 |
Why?
|
Observer Variation | 8 | 2016 | 2601 | 0.150 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3620 | 0.150 |
Why?
|
Stress, Mechanical | 6 | 2019 | 1666 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 580 | 0.150 |
Why?
|
Protein Precursors | 1 | 2022 | 1134 | 0.150 |
Why?
|
Follow-Up Studies | 15 | 2021 | 39261 | 0.150 |
Why?
|
Finite Element Analysis | 1 | 2019 | 428 | 0.140 |
Why?
|
Oximetry | 1 | 2020 | 461 | 0.140 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4625 | 0.140 |
Why?
|
Organogenesis | 1 | 2018 | 215 | 0.140 |
Why?
|
Surgical Instruments | 1 | 2019 | 385 | 0.140 |
Why?
|
Reproducibility of Results | 16 | 2019 | 20080 | 0.140 |
Why?
|
Elastic Tissue | 1 | 2016 | 65 | 0.140 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 51 | 0.130 |
Why?
|
Myocarditis | 1 | 2024 | 766 | 0.130 |
Why?
|
Veins | 1 | 2020 | 765 | 0.130 |
Why?
|
Retrospective Studies | 21 | 2023 | 80372 | 0.130 |
Why?
|
Analysis of Variance | 4 | 2017 | 6238 | 0.130 |
Why?
|
Brazil | 2 | 2017 | 1218 | 0.130 |
Why?
|
Prospective Studies | 15 | 2021 | 54303 | 0.130 |
Why?
|
Sarcomeres | 1 | 2018 | 367 | 0.130 |
Why?
|
Collagen | 3 | 2022 | 2636 | 0.130 |
Why?
|
Auditory Threshold | 3 | 2012 | 369 | 0.130 |
Why?
|
Aortography | 1 | 2017 | 420 | 0.130 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2018 | 491 | 0.130 |
Why?
|
Transducers | 2 | 2008 | 240 | 0.120 |
Why?
|
Robotics | 1 | 2022 | 874 | 0.120 |
Why?
|
Exercise | 3 | 2017 | 5787 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2015 | 2062 | 0.120 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2017 | 435 | 0.120 |
Why?
|
Cilia | 1 | 2019 | 493 | 0.120 |
Why?
|
Surgical Mesh | 1 | 2017 | 311 | 0.120 |
Why?
|
Microfilament Proteins | 2 | 2012 | 1135 | 0.120 |
Why?
|
Phenotype | 11 | 2023 | 16546 | 0.120 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1572 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 819 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.120 |
Why?
|
Risk Factors | 17 | 2022 | 74359 | 0.120 |
Why?
|
Audiometry, Pure-Tone | 2 | 2012 | 210 | 0.120 |
Why?
|
Family | 2 | 2015 | 3189 | 0.110 |
Why?
|
Swine | 7 | 2023 | 5899 | 0.110 |
Why?
|
Bacteroidaceae Infections | 2 | 2004 | 31 | 0.110 |
Why?
|
Risk Assessment | 9 | 2023 | 24123 | 0.110 |
Why?
|
Heart Aneurysm | 2 | 2005 | 115 | 0.110 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2013 | 10 | 0.110 |
Why?
|
Myofibroblasts | 1 | 2015 | 207 | 0.110 |
Why?
|
Bradycardia | 1 | 2014 | 299 | 0.110 |
Why?
|
Injections | 3 | 2015 | 830 | 0.110 |
Why?
|
Acoustic Stimulation | 3 | 2012 | 1232 | 0.100 |
Why?
|
Rupture | 1 | 2014 | 443 | 0.100 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2013 | 140 | 0.100 |
Why?
|
Organ Size | 3 | 2019 | 2254 | 0.100 |
Why?
|
Pacemaker, Artificial | 2 | 2021 | 815 | 0.100 |
Why?
|
Coronary Artery Disease | 3 | 2019 | 6659 | 0.100 |
Why?
|
Intracranial Embolism | 1 | 2014 | 192 | 0.100 |
Why?
|
Cardiomyopathies | 3 | 2021 | 1952 | 0.100 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2013 | 43 | 0.100 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 145 | 0.100 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2013 | 273 | 0.100 |
Why?
|
Blood Pressure | 4 | 2020 | 8525 | 0.100 |
Why?
|
Cochlear Nucleus | 1 | 2012 | 60 | 0.100 |
Why?
|
Troponin I | 1 | 2016 | 638 | 0.100 |
Why?
|
Myxoma | 1 | 2012 | 114 | 0.100 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2012 | 139 | 0.100 |
Why?
|
Postoperative Complications | 2 | 2012 | 15697 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2011 | 63 | 0.100 |
Why?
|
Heart | 4 | 2019 | 4393 | 0.090 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 253 | 0.090 |
Why?
|
Tricuspid Valve | 3 | 2021 | 409 | 0.090 |
Why?
|
Perceptual Distortion | 1 | 2010 | 36 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1215 | 0.090 |
Why?
|
Cadherins | 1 | 2015 | 898 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2022 | 18957 | 0.090 |
Why?
|
Hyperacusis | 1 | 2010 | 31 | 0.090 |
Why?
|
Matrix Metalloproteinases | 2 | 2016 | 392 | 0.090 |
Why?
|
Blood Flow Velocity | 4 | 2011 | 1377 | 0.090 |
Why?
|
Ventricular Pressure | 3 | 2022 | 204 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 1523 | 0.090 |
Why?
|
Ligation | 1 | 2011 | 448 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6544 | 0.090 |
Why?
|
Aortic Diseases | 2 | 2014 | 736 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20509 | 0.090 |
Why?
|
Pedigree | 4 | 2019 | 4578 | 0.090 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3465 | 0.090 |
Why?
|
Models, Animal | 3 | 2011 | 2117 | 0.080 |
Why?
|
Ischemia | 3 | 2022 | 1893 | 0.080 |
Why?
|
Inferior Colliculi | 1 | 2009 | 69 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4193 | 0.080 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1064 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2004 | 4446 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2015 | 410 | 0.080 |
Why?
|
Biopsy | 2 | 2017 | 6771 | 0.080 |
Why?
|
Chronic Disease | 6 | 2013 | 9287 | 0.080 |
Why?
|
Mesencephalon | 1 | 2010 | 332 | 0.080 |
Why?
|
Pulsatile Flow | 1 | 2009 | 321 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2012 | 378 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2017 | 10446 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2010 | 1529 | 0.080 |
Why?
|
Diastole | 3 | 2019 | 788 | 0.080 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2010 | 265 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4550 | 0.080 |
Why?
|
Prosthesis Design | 4 | 2019 | 2135 | 0.080 |
Why?
|
Phantoms, Imaging | 2 | 2008 | 2512 | 0.070 |
Why?
|
Software | 2 | 2015 | 4419 | 0.070 |
Why?
|
Equipment Design | 3 | 2017 | 3520 | 0.070 |
Why?
|
Japan | 3 | 2020 | 1369 | 0.070 |
Why?
|
Cell Communication | 1 | 2015 | 1653 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1717 | 0.070 |
Why?
|
Recurrence | 5 | 2021 | 8482 | 0.070 |
Why?
|
Gels | 1 | 2008 | 419 | 0.070 |
Why?
|
Auditory Pathways | 1 | 2009 | 237 | 0.070 |
Why?
|
Heart Rate | 4 | 2012 | 4179 | 0.070 |
Why?
|
Hypertension | 2 | 2004 | 8594 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2932 | 0.070 |
Why?
|
Corpus Callosum | 1 | 2012 | 749 | 0.070 |
Why?
|
Physical Exertion | 1 | 2010 | 662 | 0.070 |
Why?
|
Muscle Cells | 1 | 2008 | 195 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1484 | 0.070 |
Why?
|
Cause of Death | 1 | 2017 | 3725 | 0.070 |
Why?
|
Genetic Research | 1 | 2007 | 172 | 0.070 |
Why?
|
Evoked Potentials, Auditory | 1 | 2009 | 529 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12531 | 0.070 |
Why?
|
Up-Regulation | 2 | 2017 | 4122 | 0.070 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 75 | 0.070 |
Why?
|
Cytomegalovirus | 1 | 2010 | 755 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1173 | 0.060 |
Why?
|
Mutation | 4 | 2018 | 29932 | 0.060 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2009 | 866 | 0.060 |
Why?
|
Automation | 1 | 2008 | 580 | 0.060 |
Why?
|
Contrast Media | 3 | 2023 | 5305 | 0.060 |
Why?
|
Dependovirus | 1 | 2010 | 709 | 0.060 |
Why?
|
Osteoblasts | 1 | 2010 | 1142 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 1204 | 0.060 |
Why?
|
Carbamazepine | 1 | 2006 | 224 | 0.060 |
Why?
|
Brain | 1 | 2012 | 26951 | 0.060 |
Why?
|
Porphyromonas gingivalis | 2 | 2004 | 162 | 0.060 |
Why?
|
Mathematical Computing | 1 | 2005 | 143 | 0.060 |
Why?
|
Lod Score | 1 | 2005 | 602 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2873 | 0.060 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 823 | 0.060 |
Why?
|
Dilatation, Pathologic | 3 | 2014 | 527 | 0.060 |
Why?
|
Hydrogels | 1 | 2010 | 723 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2005 | 724 | 0.060 |
Why?
|
Electrocardiography | 3 | 2012 | 6414 | 0.060 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12159 | 0.060 |
Why?
|
Sex Factors | 4 | 2023 | 10547 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9280 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14660 | 0.060 |
Why?
|
Thalamus | 1 | 2010 | 1041 | 0.060 |
Why?
|
Cell Transplantation | 1 | 2006 | 472 | 0.060 |
Why?
|
Osteogenesis | 1 | 2010 | 1271 | 0.060 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2852 | 0.060 |
Why?
|
Logistic Models | 4 | 2015 | 13314 | 0.060 |
Why?
|
Recovery of Function | 3 | 2019 | 2985 | 0.060 |
Why?
|
Anthropometry | 2 | 2012 | 1348 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5125 | 0.060 |
Why?
|
Blood Volume | 1 | 2005 | 550 | 0.060 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 261 | 0.060 |
Why?
|
Heterozygote | 2 | 2018 | 2798 | 0.050 |
Why?
|
Serotonin | 2 | 2022 | 1040 | 0.050 |
Why?
|
Rome | 1 | 2022 | 28 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 829 | 0.050 |
Why?
|
Illusions | 1 | 2003 | 60 | 0.050 |
Why?
|
Cyproheptadine | 1 | 2022 | 19 | 0.050 |
Why?
|
Genetic Linkage | 2 | 2005 | 2381 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3696 | 0.050 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12626 | 0.050 |
Why?
|
Lymphangiogenesis | 1 | 2024 | 172 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2022 | 43 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2017 | 608 | 0.050 |
Why?
|
Calcium | 2 | 2022 | 5725 | 0.050 |
Why?
|
Tachycardia | 1 | 2004 | 602 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9585 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2008 | 1273 | 0.050 |
Why?
|
Cohort Studies | 6 | 2018 | 41335 | 0.050 |
Why?
|
Terrorism | 1 | 2004 | 211 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2019 | 14372 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2006 | 604 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 248 | 0.050 |
Why?
|
Coronary Artery Bypass | 3 | 2006 | 2272 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2004 | 1249 | 0.050 |
Why?
|
Linear Models | 3 | 2017 | 5877 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 461 | 0.040 |
Why?
|
Apolipoproteins E | 2 | 2004 | 1436 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1652 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 1446 | 0.040 |
Why?
|
Aging | 2 | 2017 | 8651 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2011 | 3112 | 0.040 |
Why?
|
Endothelium | 1 | 2022 | 764 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12103 | 0.040 |
Why?
|
Breath Tests | 1 | 2020 | 297 | 0.040 |
Why?
|
Mice | 9 | 2021 | 81208 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5785 | 0.040 |
Why?
|
Compliance | 1 | 2018 | 100 | 0.040 |
Why?
|
Heart Defects, Congenital | 2 | 2012 | 4673 | 0.040 |
Why?
|
Tissue Survival | 1 | 2018 | 119 | 0.040 |
Why?
|
Survival Analysis | 2 | 2016 | 10182 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 959 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11903 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3817 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2019 | 319 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2022 | 824 | 0.040 |
Why?
|
Patient Selection | 2 | 2007 | 4283 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1535 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3523 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1489 | 0.040 |
Why?
|
Prevalence | 4 | 2020 | 15687 | 0.040 |
Why?
|
Cardiac Output, Low | 1 | 2018 | 192 | 0.040 |
Why?
|
Endocardium | 2 | 2012 | 246 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1376 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1266 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2782 | 0.030 |
Why?
|
Massachusetts | 2 | 2016 | 8803 | 0.030 |
Why?
|
Dietary Fats | 1 | 2004 | 1992 | 0.030 |
Why?
|
Registries | 3 | 2020 | 8469 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6965 | 0.030 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2015 | 4 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3084 | 0.030 |
Why?
|
Motion | 2 | 2012 | 779 | 0.030 |
Why?
|
Genetic Markers | 2 | 2018 | 2608 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 369 | 0.030 |
Why?
|
Zebrafish | 2 | 2019 | 2997 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2022 | 1548 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1355 | 0.030 |
Why?
|
Morphogenesis | 1 | 2019 | 740 | 0.030 |
Why?
|
France | 1 | 2016 | 511 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17790 | 0.030 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2017 | 461 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1827 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1791 | 0.030 |
Why?
|
Elastin | 1 | 2016 | 301 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2016 | 2362 | 0.030 |
Why?
|
Random Allocation | 2 | 2012 | 2394 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 631 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2016 | 653 | 0.030 |
Why?
|
New York City | 1 | 2016 | 724 | 0.030 |
Why?
|
Receptors, Angiotensin | 1 | 2014 | 141 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1031 | 0.030 |
Why?
|
Psychological Techniques | 1 | 2013 | 47 | 0.030 |
Why?
|
Diet, Atherogenic | 2 | 2004 | 93 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 566 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7269 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2017 | 1850 | 0.030 |
Why?
|
Functional Laterality | 2 | 2010 | 2253 | 0.030 |
Why?
|
Algorithms | 2 | 2020 | 13981 | 0.030 |
Why?
|
Endocardial Cushions | 1 | 2012 | 12 | 0.030 |
Why?
|
Genetic Loci | 1 | 2022 | 2618 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2629 | 0.030 |
Why?
|
Cell Lineage | 2 | 2012 | 2533 | 0.030 |
Why?
|
Thrombosis | 1 | 2006 | 3052 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 478 | 0.030 |
Why?
|
Tryptophan Hydroxylase | 1 | 2012 | 94 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3765 | 0.020 |
Why?
|
Proteome | 1 | 2022 | 1855 | 0.020 |
Why?
|
Cell Movement | 2 | 2015 | 5206 | 0.020 |
Why?
|
New York | 1 | 2014 | 875 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5434 | 0.020 |
Why?
|
Signal Transduction | 3 | 2016 | 23376 | 0.020 |
Why?
|
Heart Diseases | 1 | 2004 | 2809 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2002 | 2781 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3280 | 0.020 |
Why?
|
Captopril | 1 | 2012 | 265 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1499 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2020 | 1921 | 0.020 |
Why?
|
Transglutaminases | 1 | 2012 | 197 | 0.020 |
Why?
|
Body Patterning | 1 | 2015 | 632 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2015 | 1342 | 0.020 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 324 | 0.020 |
Why?
|
Valine | 1 | 2012 | 409 | 0.020 |
Why?
|
Osteocalcin | 1 | 2010 | 274 | 0.020 |
Why?
|
Chick Embryo | 1 | 2012 | 981 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 13451 | 0.020 |
Why?
|
Sus scrofa | 1 | 2011 | 433 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1871 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3505 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1578 | 0.020 |
Why?
|
Actins | 1 | 2017 | 2049 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9335 | 0.020 |
Why?
|
Stroke | 2 | 2021 | 9962 | 0.020 |
Why?
|
Sound Spectrography | 1 | 2009 | 113 | 0.020 |
Why?
|
Perceptual Masking | 1 | 2009 | 90 | 0.020 |
Why?
|
Chondrogenesis | 1 | 2010 | 239 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1006 | 0.020 |
Why?
|
Mesoderm | 1 | 2012 | 672 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2802 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2895 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2295 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 12960 | 0.020 |
Why?
|
Adipogenesis | 1 | 2010 | 358 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12446 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2012 | 951 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18416 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2392 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2893 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2698 | 0.020 |
Why?
|
Coronary Disease | 1 | 2002 | 5990 | 0.020 |
Why?
|
Noise | 1 | 2009 | 280 | 0.020 |
Why?
|
Ventricular Septum | 1 | 2007 | 76 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11071 | 0.020 |
Why?
|
Computer Systems | 1 | 2008 | 470 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6218 | 0.020 |
Why?
|
Tetrazoles | 1 | 2012 | 905 | 0.020 |
Why?
|
Incidence | 3 | 2014 | 21392 | 0.020 |
Why?
|
Models, Biological | 1 | 2022 | 9467 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2006 | 278 | 0.020 |
Why?
|
Young Adult | 3 | 2018 | 58741 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4925 | 0.010 |
Why?
|
Serum Amyloid A Protein | 1 | 2004 | 127 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6538 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1784 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3568 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12808 | 0.010 |
Why?
|
Movement Disorders | 1 | 2007 | 459 | 0.010 |
Why?
|
Postoperative Period | 1 | 2008 | 1818 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5201 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8313 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2002 | 182 | 0.010 |
Why?
|
Founder Effect | 1 | 2003 | 186 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2014 | 4563 | 0.010 |
Why?
|
Sinus of Valsalva | 1 | 2002 | 60 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4090 | 0.010 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2003 | 143 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1490 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2002 | 575 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2002 | 25942 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 2116 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2002 | 1154 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9716 | 0.010 |
Why?
|
Acetylcholine | 1 | 2002 | 629 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12766 | 0.010 |
Why?
|
Cicatrix | 1 | 2006 | 782 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2648 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14495 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15789 | 0.010 |
Why?
|
Pericardium | 1 | 2003 | 675 | 0.010 |
Why?
|
Adenoviridae | 1 | 2002 | 1084 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 978 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2002 | 951 | 0.010 |
Why?
|
Drug Carriers | 1 | 2002 | 709 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2002 | 1006 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1955 | 0.010 |
Why?
|
Fluorocarbons | 1 | 2002 | 488 | 0.010 |
Why?
|
Catheterization | 1 | 2002 | 1432 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1456 | 0.010 |
Why?
|
Dogs | 1 | 2002 | 3841 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 2764 | 0.010 |
Why?
|
Anxiety | 1 | 2010 | 4538 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11481 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2007 | 2758 | 0.010 |
Why?
|
Brain Mapping | 1 | 2009 | 6568 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 87810 | 0.010 |
Why?
|
Aorta | 1 | 2002 | 2039 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6360 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2002 | 3380 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6068 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12965 | 0.010 |
Why?
|
Depression | 1 | 2010 | 8044 | 0.010 |
Why?
|
Genetic Testing | 1 | 2003 | 3531 | 0.010 |
Why?
|
Gene Expression | 1 | 2002 | 7588 | 0.010 |
Why?
|
Databases, Factual | 1 | 2005 | 8035 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2003 | 3127 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2003 | 2557 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23711 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22023 | 0.000 |
Why?
|
Child, Preschool | 1 | 2003 | 42063 | 0.000 |
Why?
|
Child | 1 | 2003 | 79806 | 0.000 |
Why?
|